Cargando…
Change in Trajectories of Adherence to Lipid‐Lowering Drugs Following Non‐Fatal Acute Coronary Syndrome or Stroke
BACKGROUND: Poor adherence to cardioprotective drugs remains a concern among patients for secondary prevention. A better understanding of adherence fluctuations before and after critical health events may inform approaches for addressing or preventing poor adherence. Therefore, we assessed trajector...
Autores principales: | Zongo, Arsène, Simpson, Scot, Johnson, Jeffrey A., Eurich, Dean T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912969/ https://www.ncbi.nlm.nih.gov/pubmed/31771443 http://dx.doi.org/10.1161/JAHA.119.013857 |
Ejemplares similares
-
Optimal threshold of adherence to lipid lowering drugs in predicting acute coronary syndrome, stroke, or mortality: A cohort study
por: Zongo, Arsène, et al.
Publicado: (2019) -
Effect of a pharmacy comprehensive chronic diseases care plan on use of lipid-lowering drugs among patients with hypertension
por: Zongo, Arsène, et al.
Publicado: (2021) -
The Darkening Cloud of Diabetes: Do trends in cardiovascular risk management provide a silver lining?
por: Eurich, Dean T., et al.
Publicado: (2008) -
Substance Use Disorders and Psychoactive Drug Poisoning in Medically
Authorized Cannabis Patients: Longitudinal Cohort Study
por: Zongo, Arsène, et al.
Publicado: (2021) -
Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study
por: Sharma, Vishal, et al.
Publicado: (2020)